RBBP7 and prostate carcinoma: However, in prostate cancer, upregulation of EZH2 suppresses the levels of the RBBP7/HNF1B transcriptional complex via direct inhibition of HNF1B expression, promoting SLUG transcription [107] (Fig. 5C).